cepoLABRX - BIOGENIC EV COMPLEX

Designed to be used in a professional setting after aesthetic procedures, or as part of post-procedure skin care routines, this product helps soothe sensitive-looking skin after laser and energy-based treatments and supports the appearance of skin recovery during post-procedure skin care routines. Its hero ingredient is a biogenic complex derived from a strain of Ceriporia lacerate, a type of fungus, purpose-selected for cepoLab’s RX line, which results in a distinct extracellular vesicle and secondary metabolite profile. This is designed to deliver a more precise biogenic response for post-procedure skin, compared to the main cepoLAB line. In a clinical study conducted by the Korea Dermatology Research Institute, after using the product for four weeks, skin density improved by 15.79% on the treated side vs. 4.39% on the untreated side.

November / 12th / 2025

RX / 100ml / € 110.3 RX Professional USE / 4ml x 30EA / € 139.2

cepoLAB RX is distinguished by its use of a purpose-selected Ceriporia lacerata strain, rather than increased concentration or reformulation. This strain differentiation results in a unique extracellular vesicle and secondary metabolite profile, enabling a more precise and targeted biogenic response. The formulation is intentionally minimal, preservative-free, and optimized for post-procedure skin conditions. Its innovation lies in aligning strain-level biotechnology with real clinical use, as the product is already widely adopted in Korean dermatology clinics as post-procedure supportive care. This combination of strain science, precision formulation, and proven professional use sets cepoLAB RX apart.

- Supports the appearance of skin comfort following aesthetic procedures - Helps soothe sensitive-looking skin after laser and energy-based treatments - Supports the appearance of skin recovery during post-procedure skincare routines - Helps improve the appearance of skin firmness and density - Suitable for use immediately after professional aesthetic procedures - Designed for skin experiencing temporary dryness, imbalance, or discomfort post-procedure - Precision-focused biogenic skincare formulated with a purpose-selected Ceriporia lacerata strain - Minimal, preservative-free formulation suitable for professional and clinic-guided use - Commonly incorporated into post-procedure skincare routines in Korean dermatology clinics - Appropriate for professional, derma-oriented skincare environments

- Clinical evaluation conducted by: Korea Dermatology Research Institute
- Study design: Split-face, controlled clinical evaluation following aesthetic procedure
- Procedure type: Energy-based aesthetic treatment (Potenza)
- Participants: 24 adult women aged 30–59
- Study duration: 4 weeks
- Application method: cepoLAB RX applied twice daily to one side of the face; untreated side used as control

Key Results (Appearance-based evaluation):
- The treated side showed a 3.6× greater improvement in the appearance of skin density compared to the untreated control side
- The treated side demonstrated a 2.3× greater improvement in the appearance of skin firmness (lifting-related appearance) compared to the control
- Skin density improvement rate: 15.79% on treated side vs. 4.39% on untreated side

Additional Observations:
- The product was well tolerated under post-procedure skin conditions
- No adverse dermatological reactions were reported during the study period
- Results support the product’s role as post-procedure supportive skincare, focusing on visible skin condition and appearance rather than medical treatment

EU Cosmetic Regulation: - Registered on the CPNP (Cosmetic Products Notification Portal) - Safety assessment and compliance completed in accordance with EU Cosmetic Regulation (EC) No. 1223/2009 EU & UK Safety Compliance: - SCPN (UK Submit Cosmetic Product Notification) completed for the UK market United States: - Compliant with the U.S. FDA MoCRA (Modernization of Cosmetics Regulation Act) requirements - Facility registration and product listing completed as required Japan: - Registered and compliant under PMDA / PMD Act regulations for cosmetic products Eurasian Market: - Approved under EAC (Eurasian Conformity) for distribution in EAEU member states Manufacturing & Quality: - Manufactured in facilities compliant with international cosmetic GMP standards - Safety documentation, ingredient review, and regulatory dossiers prepared in accordance with each regional authority Global Readiness: - Regulatory approvals across major global markets support immediate professional and commercial distribution - Compliance framework aligned with professional, derma-oriented skincare positioning

Hero Ingredient: Biogenic complex derived from a purpose-selected strain of Ceriporia lacerata - The RX line utilizes a strain differentiated from those used in existing cepoLAB products. - This strain selection results in a distinct extracellular vesicle (EV) and secondary metabolite profile, designed to deliver a more precise biogenic response under post-procedure skin conditions. Formulation Concept: - cepoLAB RX is formulated as a precision-focused, minimal post-procedure skincare solution. - The formulation prioritizes biogenic integrity and skin comfort, particularly for skin experiencing temporary sensitivity or imbalance following aesthetic procedures. - Rather than increasing concentration or layering multiple actives, the formulation relies on strain-level differentiation to achieve targeted functionality. Key Formulation Characteristics: - High-content biogenic ingredient base derived from Ceriporia lacerata strain - Minimal ingredient composition to reduce formulation burden on post-procedure skin - Preservative-free formulation - Free from artificial fragrance and colorants - Designed for immediate post-procedure use in professional skincare environments Ingredient Philosophy: - The formulation avoids unnecessary additives that may interfere with skin comfort during post-procedure periods. - Supporting ingredients are selected to maintain formula stability and compatibility while preserving the activity of the biogenic components. - All ingredients are selected and reviewed in accordance with global cosmetic regulatory standards. Suitability & Use Context: - Suitable for professional and clinic-guided skincare routines - Commonly incorporated into post-procedure skincare protocols in Korean dermatology clinics - Designed to integrate seamlessly as a first-step product following cleansing Regulatory & Safety Considerations: - Ingredient composition complies with major global cosmetic regulations, including EU, US, Japan, and Eurasian markets - Safety assessments completed in accordance with regional cosmetic regulatory requirements This formulation reflects cepoLAB RX’s core philosophy: precision through strain selection, minimalism in formulation, and relevance to real post-procedure skincare practice.

- Purpose-selected Ceriporia lacerata strain technology delivering a distinct biogenic profile - Extracellular vesicle (EV)–based biogenic delivery system designed to support targeted skin interaction - Precision-focused formulation optimized for post-procedure skin conditions - Minimal formulation technology designed to reduce formulation burden on sensitive-looking skin - Preservative-free system engineered for professional skincare environments - First-step delivery concept designed for immediate use after cleansing - Lightweight, fast-absorbing texture suitable for compromised or sensitized skin states - Packaging designed for hygienic, controlled dispensing in clinical and professional settings - Formulation and production processes aligned with global cosmetic GMP standards - Designed for integration into professional post-procedure skincare protocols - Technology developed to maintain biogenic stability throughout product use - Suitable for clinic-guided and professional skincare routines requiring consistency and precision

- Due to the recent product launch, cepoLAB RX does not yet carry finalized third-party sustainability certifications - Multiple sustainability-related certifications are currently under application or in progress, reflecting the brand’s structured roadmap toward eco-aligned credentials Certifications in Progress / Applied: - EU Ecolabel – application in progress - Vegan Certification – application in progress - FSG (Free from Specific Groups) – application submitted - Soy Ink certification – application submitted - Organic-related certifications – application submitted for applicable formulation and material components Sustainability-Oriented Development Approach: Certification roadmap aligned with environmentally responsible formulation, production, and packaging standards - Minimal formulation strategy designed to reduce unnecessary ingredients and formulation complexity - Preservative-free formulation supporting reduced use of synthetic additives - Manufacturing processes aligned with international cosmetic GMP standards - Long-term strain-based biotechnology approach focused on consistency, efficiency, and responsible resource use Commitment Statement: - cepoLAB RX is designed with the intention to meet recognized environmental and ethical standards, with certification acquisition planned as an integral part of the product’s lifecycle following launch

- Use immediately after aesthetic procedures or as part of post-procedure skincare routines - Apply after cleansing as the first step of skincare - Dispense an appropriate amount and gently spread over the face - Pat lightly to aid absorption; do not massage aggressively - Use twice daily, morning and evening - Suitable for daily use during the post-procedure recovery period - Can be used alone or followed by moisturizer or sunscreen as needed - Designed for professional, clinic-guided, or post-treatment skincare routines

Market Positioning: - Professional, derma-oriented skincare solution designed for post-procedure use - Precision-focused biogenic skincare based on strain-differentiated biotechnology - Positioned as a first-step supportive care product following aesthetic procedures Distribution Channels: - Primarily distributed through dermatology clinics, aesthetic clinics, medical spas, and professional skincare environments - Promoted and introduced through offline professional channels, including clinical networks and aesthetic communities - Product exposure and awareness supported through industry publications, news features, and scientific conferences Current Markets (Available): - South Korea: actively used in dermatology clinics and aesthetic settings as part of post-procedure skincare routines Desired / Target Markets: - Europe (EU & UK): professional dermatology and aesthetic channels - United States: professional clinics and derma-focused distribution - Japan: clinic-guided and professional skincare markets - Eurasian markets: professional and medical-aesthetic distribution channels

Precision biogenic skincare designed for post-procedure use, powered by strain-differentiated Ceriporia lacerata technology. Channels & Editorial Pitch: While a standalone consumer website is currently under development, cepoLAB RX is actively promoted through professional offline channels. Brand exposure is supported by industry news coverage, scientific publications, and presentations at professional and academic conferences, including dermatology and aesthetic-related events. The product is introduced directly to dermatologists, aesthetic practitioners, medical spas, and professional skincare providers, reinforcing its clinical relevance and professional positioning. Editorial communication focuses on strain-level biotechnology, precision formulation, and real-world post-procedure use, rather than mass-market promotion. This professional-first approach reflects the brand’s strategy to establish credibility and adoption within expert communities prior to broader digital expansion.